Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000052

Chief Financial Officer sold 672 shares at $32.57 ($21,887)

  • Chief Financial Officer acquired 2,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jones Cecilia · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-01 Exercise or conversion : show line 1 in the form 10b5-1 +2,000 15,512 D
2024-03-05 Sale : show line 2 in the form 10b5-1 −672 $32.57 $21,887 14,840 D
Open-market sales · 672 sh · avg $32.57 · $21,887

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 3 in the form 10b5-1 Restricted stock units +17,000 17,000 D
2024-03-01 Grant or award : show line 4 in the form 10b5-1 Stock options (right to buy) +60,000 60,000 D
2024-03-01 Exercise or conversion : show line 5 in the form 10b5-1 Restricted stock units −2,000 4,000 D
Loading xslF345X05/wk-form4_1709673462.xml…